MEADOWS REGIONAL MEDICAL CENTER
1. Target Overview & Investment Thesis
MEADOWS REGIONAL MEDICAL CENTER is a 57-bed suburban community hospital in nan, GA with $91.8M in net patient revenue and a -18.8% operating margin. The hospital serves a payer mix of 19.5% Medicare, 6.9% Medicaid, and 73.6% commercial.
Thesis: Turnaround. Our ML models identify $6.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -18.8% to -11.4% (+736bps).
| Net Revenue HCRIS | $91.8M |
| Current EBITDA COMPUTED | $-17.2M |
| Operating Margin COMPUTED | -18.8% |
| Occupancy HCRIS | 80.7% |
| Revenue / Bed COMPUTED | $1.6M |
| Net-to-Gross HCRIS | 17.8% |
| Distress Probability ML | 39.4% |
2. Market Context & Competitive Position
GA has 165 Medicare-certified hospitals with a median operating margin of -2.8%. The target's margin of -18.8% places it below the state median. Among 68 size-comparable peers (28-114 beds), the median margin is -1.2%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (28-114), prioritizing same-state peers. 68 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| MEADOWS REGIONAL MEDICAL CENTE (Target) | GA | 57 | $91.8M | -18.8% |
| TANNER MEDICAL CENTER-VILLA RI | GA | 58 | $289.8M | 33.3% |
| PAULDING MEDICAL CENTER | GA | 112 | $288.5M | 9.0% |
| DOUGLAS HOSPITAL | GA | 112 | $217.2M | -0.8% |
| NORTHSIDE HOSPITAL - DULUTH | GA | 87 | $193.2M | -3.1% |
| ADVENTHEALTH GORDON | GA | 69 | $188.5M | -3.4% |
| COLQUITT REGIONAL MEDICAL CENT | GA | 99 | $173.8M | -17.0% |
| KENNESTONE HOSPITAL AT WINDY H | GA | 55 | $160.5M | 0.7% |
| PIEDMONT NEWTON HOSPITAL | GA | 94 | $148.5M | 4.8% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $6.8M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $1.9M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $1.8M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $1.8M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $1.1M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $59K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-17.2M |
| + RCM Uplift | +$6.8M |
| Pro Forma EBITDA | $-10.5M |
| Current Margin | -18.8% |
| Pro Forma Margin | -11.4% |
| WC Released (1x) | $3.5M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-26.5M | $-46.0M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-26.5M | $-59.2M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-23.8M | $-45.5M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-23.8M | $-56.7M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-29.1M | $-71.2M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-29.1M | $-87.8M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Low | Low net-to-gross ratio | Large contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 68 hospitals with 28-114 beds
- Same-state prioritization (n=69)
- Comp margins: P25=-14.4% / P50=-1.2% / P75=7.2%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.